Trial Profile
Effects of YF476, a Gastrin Antagonist, and Rabeprazole, a Proton Pump Inhibitor, Alone and in Combination, on Gastric Function in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Netazepide (Primary) ; Rabeprazole
- Indications Gastritis; Hyperchlorhydria; Hyperplasia
- Focus Therapeutic Use
- Sponsors Trio Medicines
- 27 Apr 2015 New trial record